Chinese Journal of Cancer

Aims & Scope

In July 2008, Landes Bioscience and Sun Yat-sen University Cancer Center began co-publishing the international, English-language version of AI ZHENG or the Chinese Journal of Cancer (CJC).

CJC publishes original research, reviews, extra views, perspectives, supplements, and spotlights in all areas of cancer research.

The primary criteria for publication in CJC are originality, outstanding scientific merit, and general interest.

The Editorial Board is composed of members from around the world, who will strive to maintain the highest standards for excellence in order to generate a valuable resource for an international readership.

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Directory of Open Access Journals (DOAJ)

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.

Policy Links

This section provides access to essential policy documents, guidelines, and resources related to the journal’s publication and submission processes.

• Aims scope
• Homepage
• Oa statement
• Author instructions
• License terms
• Review url
• Board url
• Copyright url
• Plagiarism url
• Preservation url
• Apc url
• License

Plagiarism Policy

This journal follows a plagiarism policy. All submitted manuscripts are screened using reliable plagiarism detection software to ensure originality and academic integrity. Authors are responsible for proper citation and acknowledgment of all sources, and any form of plagiarism, including self-plagiarism, will not be tolerated.

For more details, please refer to our official: Plagiarism Policy.

APC Details

The journal’s Article Processing Charge (APC) policies support open access publishing in Medicine, ensuring accessibility and quality in research dissemination.

This journal requires an Article Processing Charge (APC) to support open access publishing, covering peer review, editing, and distribution. The current APC is 1,370.00 GBP. Learn more.

Explore journals without APCs for alternative publishing options.

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• The prevalence and prevention of nasopharyngeal carcinoma in China

  Citation: 454

  Authors: Su-Mei, Malcolm J., Chao-Nan

• Epidemiologic differences in esophageal cancer between Asian and Western populations

  Citation: 240

  Authors: Han-Ze, Guang-Fu, Hong-Bing

• Breast cancer resistance protein (BCRP/ABCG2): its role in multidrug resistance and regulation of its gene expression

  Citation: 238

  Authors: Takeo, Douglas D.

• Apoptosis and the target genes of microRNA-21

  Citation: 235

  Authors: Lindsey E. Becker, Yong

• Multidrug resistance associated proteins in multidrug resistance

  Citation: 231

  Authors: Kamlesh, Atish, Rishil J., Zhe-Sheng

• The recurrence and survival of oral squamous cell carcinoma: a report of 275 cases

  Citation: 226

  Authors: Bo, Shu, Kai, Xu-Dong

• The International Agency for Research on Cancer (IARC) evaluation of the carcinogenicity of outdoor air pollution: focus on China

  Citation: 224

  Authors: Dana, Wei, Guosheng

• East meets West: ethnic differences in epidemiology and clinical behaviors of lung cancer between East Asians and Caucasians

  Citation: 203

  Authors: Wei, David C.

• Epithelial-mesenchymal transition in breast cancer progression and metastasis

  Citation: 181

  Authors: Yifan, Binhua P.

• Identification of plasma microRNA-21 as a biomarker for early detection and chemosensitivity of non-small cell lung cancer

  Citation: 174

  Authors: Juan, Wen, Cheng-Jun, Yi-Qian, Zhu, Ting, Yong-Qian